Alexion Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Alexion Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Alexion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Alexion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 3.46 | |
| Fifty Two Week Low | 99.91 | |
| Target High Price | 205.00 | |
| Fifty Two Week High | 187.45 | |
| Target Low Price | 166.00 |
Alexion |
Alexion Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Alexion Pharmaceuticals on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Alexion Pharmaceuticals or generate -100.0% return on investment over 90 days. Alexion Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Alexion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alexion Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alexion Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alexion Pharmaceuticals, and traders can use it to determine the average amount a Alexion Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ALXN |
Based on monthly moving average Alexion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alexion Pharmaceuticals by adding Alexion Pharmaceuticals to a well-diversified portfolio.
Alexion Pharmaceuticals Fundamentals Growth
Alexion Stock prices reflect investors' perceptions of the future prospects and financial health of Alexion Pharmaceuticals, and Alexion Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alexion Stock performance.
| Return On Equity | 4.43 | |||
| Return On Asset | 10.08 | |||
| Profit Margin | 10.89 % | |||
| Operating Margin | 52.12 % | |||
| Current Valuation | 39.17 B | |||
| Shares Outstanding | 221.02 M | |||
| Price To Earning | 58.24 X | |||
| Price To Book | 3.19 X | |||
| Price To Sales | 6.33 X | |||
| Revenue | 6.26 B | |||
| EBITDA | 3.26 B | |||
| Cash And Equivalents | 3.47 B | |||
| Cash Per Share | 15.70 X | |||
| Total Debt | 2.88 B | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 56.21 X | |||
| Cash Flow From Operations | 3.09 B | |||
| Earnings Per Share | 3.08 X | |||
| Total Asset | 13.13 B | |||
| Retained Earnings | 5.01 B | |||
| Current Asset | 2.43 B | |||
| Current Liabilities | 718.25 M | |||
Things to note about Alexion Pharmaceuticals performance evaluation
Checking the ongoing alerts about Alexion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alexion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alexion Pharmaceuticals is not yet fully synchronised with the market data | |
| Alexion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Alexion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Over 88.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Alexion Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alexion Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Alexion Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alexion Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alexion Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alexion Pharmaceuticals' stock. These opinions can provide insight into Alexion Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Alexion Stock
If you are still planning to invest in Alexion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alexion Pharmaceuticals' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |